Could circRNA be a new biomarker for pre‐eclampsia?
Sign Up to like & getrecommendations! Published in 2019 at "Molecular Reproduction and Development"
DOI: 10.1002/mrd.23262
Abstract: Pre‐eclampsia is a devastating complication of pregnancy which is characterized by hypertension and proteinuria in pregnant women. Pre‐eclampsia is important as it is the leading cause of death. Moreover, untreated pre‐eclampsia might lead to other… read more here.
Keywords: could circrna; biomarker; circrna new; pre eclampsia ... See more keywords
CircRNA: A new class of targets for gastric cancer drug resistance therapy
Sign Up to like & getrecommendations! Published in 2023 at "Pathology and Oncology Research"
DOI: 10.3389/pore.2023.1611033
Abstract: Gastric cancer (GC) is one of the most common malignancies worldwide. Patients with advanced GC need palliative care to ensure survival. This includes the use of chemotherapy agents, such as cisplatin, 5-fluorouracil, oxaliplatin, paclitaxel, and… read more here.
Keywords: circrna new; drug; gastric cancer; drug resistance ... See more keywords
circRNA: A New Biomarker and Therapeutic Target for Esophageal Cancer
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10071643
Abstract: Circular RNAs (circRNAs) comprise a large class of endogenous non-coding RNA with covalently closed loops and have independent functions as linear transcripts transcribed from identical genes. circRNAs are generated by a “back-splicing” process regulated by… read more here.
Keywords: therapeutic target; esophageal cancer; biomarker therapeutic; circrna new ... See more keywords